AMA submission on the Medicines Australia Code of Conduct Review

25 Sep 2013

The AMA supports increased transparency measures in addition to those already voluntarily undertaken by Medicines Australia. However it is critical that careful thought is given to the development of a model for reporting industry payments to individual practitioners. A successful reporting model should provide information to enable patients to make informed decisions about their healthcare options taking into account the context and nature of their practitioner's involvement with companies.